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Summary, discussion, and conclusions
Colorectal cancer is the third commonest cancer in men, and the second commonest in
wornen. Resection is the standard therapy, and results in a five-year survival rate of around
50%. Liver metastases occur in about 40 -70% of patients during the course of their disease,
but in only l0 - 15% liver metastases are init ialiy l imited to the l iver. In these patients, partial
liver resection offers the only chance for cure. Unforfunately, only 25oÁ of the patients after
l iver resection wil l be definitely cured.
The liver is a unique organ, in that, after removal or destruction of liver cell mass, it is able to
restore liver tissue by a process, which is called regeneration. This restorative capacity is
regulated by various growth factors and cytokines generated in the liver itself, but also by
distant organs and tissues. Tumor cells, although behaving more autonomous than non-
transformed cells, are also influenced by growth factors. The common role of growth factors
in liver regeneration and tumor growth, led to the hypothesis that changes in serum growth
factor levels, induced by partial hepatectomy, might also influence tumor growth of
micrometastases. This hypothesis is tested in this thesis, using an experimental animal model
and by analyzing serum growth factor levels and growth factor(receptor) expression on
human colorectal liver metastases.
Section I. Introduction
Chapter I gives a general introduction to the topic and formulates the questions to be
ansrvered in the ensuing chapters. In chapter 2, a review is presented on the various
mechanisms which can potentially play a role in the interaction between liver regeneration
and tumor growth.
Section II. Experimental studies
The aim of the experimental studies, performed in rats, is to investigate whether increased
tumor growth after partial liver resection is restricted to the liver or also occurs outside the
liver, and whether this is related to changes in serum composition. The experiments described
in Chapter 3 demonstrate that, 14 days after removal of 70oÁ of the (non-tumor bearing)
iiver, tumors in the remnant liver had a tumor weight which was twice as high as that in sham
operated rats. Tumors placed beneath the renal capsule, did not show this difference in
weight, suggesting that tumor growth stimulation is restricted to tumors in the liver and not
elsewhere. In order to differentiate between liver related changes and changes in serum
composition as an explanation for the differences in tumor growth, tumor cells were cultured
in the presence of portal and systemic serum, which was obtained at days one and 14 after
partial hepatectomy or sham operation. These experiments did not show a difference in
proliferation (measured by thymidine incorporation) between tumor cells cultured in
hepatectomy serum and sham semm. If, however, hepatocytes were added to these culfures, it
was found that tumor cells had a higher proliferation rate than tumor cells cultured separately.
It appeared that this increased tumor cell proliferation only occurred if the ratio tumor
cells:hepatocytes was l: l or l:10, but not in a ratio of 10:1. These findings suggest that
increased tumor growth after hepatectomy is more likely to be explained by direct (paracrine)
stimulation of fumor cells by hepatocytes than by changes in serum composition at days I and
l4 after partial hepatectomy. It might also be, however, that changes in growth factor semm
concentration after partial hepatectomy, are time dependent, and that they occur at other time
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intervals than at days one and l4 after partial hepatectomy. Therefore, in the experiments
described in chapter 4, tumor cells were cultured in portal and systemic serum, obtained frori i
rats at days one, three and l4 day after 70oÁ partial hepatectomy or sham operation. Serum
obtained at day three after operation, added to tumor cell cultures, revealed that proliferation
(measured by thymidine incorporation into DNA) was 25 - 40% higher in tumor cells cultured
in portal hepatectomy serum than in sham operated portal serum. Addition of systemic
hepatectomy serum obtained at day 14 resulted in a 30% higher proliferation rate in tumoi
cells as compared to (day 14) systemic serun-r of sham operated rats. A possibie explanation
for the fact that the experiments described in chapter 4, using day l4 systemic h.epatectomy
serum, resulted in a higher tumor cell proliferation, whereas the same serum experiments in
chapter 3 did r-rot, could be the difference in technique of measuring cell proliferation. Also,
changes in epidermal growth factor receptor (EGFr) expression on tumor cells cultured in
hepatectomy and sham serum, from portal and systemic origin obtained at day 3, were
analyzed as a possible explanation for differences in tumor growth. Other investigators
showed that growth factors can influence EGFr expression on cells, and changes in growth
factor serum concentration could result in an altered EGFr expression. We used
immunocytochemistry, northern blot analysis and ligand binding assay to determine EGFr
expression and it appeared that the increased proliferation of tumor cells was not mediated by
upregulation of EGFr by the various types of sera used.
In order to study cell proliferation in humans, it is necessary to use techniques that do not
need the administration of potentially toxic materials, l ike BrdU or [rH]thymidine. A naturally
occurring antigen, expressed in proliferating cells, is proliferating cell nuclear antigen
(PCNA). Immunostaining of this antigen makes it possible to quantify cell prolif-eration i
hurrans. Also, analysis of S-phase labeled nuclei, using flow cytometry, is a method used for
proliferation assays. These techniques, however, need to be validated in the setting of l iver
regeneration in the presence of (micro)metastases. It was, for instance, shown that PCNA
expression can be upregulated, without concomitant increase in thynridine labeling, in the
presence of growth factors produced by tumors. In chapter 5 Í'low cytometry and PCNA
immunostaining are studied in rats with l iver metastases, conrparing l iver cell proliferation in
partially hepatectomized and sham operated rats at days one, two, three, four and l0 after
operation. It was found that both PCNA expression and flow cytometric analysis of S-phase
nuclei, nicely correlated with BrdU immunostaining, and that these techniques are well suited
for the study of l iver cell proliferation in tumor bearing rats. The validation of these
techniques, makes it possible to apply those in human beings.
Sect ion I I I .  Cl in ical  studies
The aim of these studies is to test the hypothesis that partial hepatectonly, and the ensuing
regeneration response, is associated with an increase in growth factor serum levels, which
could potentially influence growth rate of occult micronretastases in man. To this end, the
serum growth factor response in patients after partial hepatectomy was compared to that in
patients after laparotorny or cryosurgery, in whom a regeneration response is not foreseen.
Furthermore, the expression of growth factors and their receptors in colorectal liver




One of the growth Íàctors important for liver regeneration and tumor growth is transforming
growth factor s (TGFcr). Chapter 6 describes the expression of this growth factor and its
receptor (EGFr) in colorectal liver metastases and corresponding primary colorectal
carcinomas in relation to prognosis. Expression of the tumor suppressor gene p53 and
proliferation rate were also studied. It was found that higher TGFa expression in liver
metastases was associated with unfavorable prognostic characteristics of the primary tumor.
Expression of p53 and the proliferation marker Ki67 were not associated with
clinicopathological characteristics of the primary tumor or the metastasis. Using multivariate
analysis, it appeared that p53 expression, absence of EGFr expression and a lower 'IGFcr
expression in the liver metastasis than in the primary tumor, was associated with a better
prognosis after partial hepatectomy than in patients with absence of p53 expression, EGFr
expression and a higher TGFa expression in the liver metastasis than in the primary tumor.
Other growth factors/cytokines for which a role in liver regeneration has been described are
interleukin-6 (IL-6) and hepatocyte growth factor (HGF). Experiments in rats suggested that
IL-6 initiates HGF production and thereby induce liver regeneration. The effect of
adrninistration of recombinant human lL-6, in cancer patients participating in a phase I-lI
study, on HGF serum levels was the topic of the study in chapter 7. HGF levels were
measured on days 1,2,3,8 and l5 after intravenous IL-6 infusion (day l) and subcutaneous
IL-6 administration for the subsequent 6 days, It was found that at days three and eight,
median HGF levels were increased to l24oÁ and 157oÁ respectively, as compared to serum
levels at day l. At day 8, the increase in HGF levels were IL-6 dose dependent. It can be
concluded that solely administered IL-6 induced an upregulation of HGF production.
The fact that in vitro experiments revealed that serum from partially hepatectomized rats
stirnulated tumor cell growth, suggest that changes in serum composition after hepatectomy
occur. Therefore, the aim of the study presented in chapter 8 was to compare the serum
response of various growth factors after laparotomy or partial hepatectomy in patients with
colorectal liver metastases. We choose to analyze changes in serum growth factor
concentration of those growth factors which play a dominant role in liver regeneration,
namely epidermal growth factor (EGF), HGF, IL-6 and insulin-like-growth factor-I (IGF-I).
Preoperative levels of the growth factors were comparable in both groups. The response,
measured from day 0 until the l0'h postoperative day, was not different in both groups except
for IGF-I. This growth factor, demonstrated a lower response in hepatectomized patients than
in laparotomized patients. In general, these findings suggest hat the systemic response of
growth factors is already initiated by laparotomy, and that partial liver resection has no
additional effect on this response. The lower IGF-I response in hepatectomized patients, could
be related to tumor growth, because IGF-I is knorvn to induce apoptosis. This finding might
be of importance because the phenomenon of increased tumor growth after partial liver
resection, found in rats, might thus be related to a decrease in tumor apoptotic rate instead of
an increase in tumor proliferation rate. In the same chapter the results are presented of a
comparison between growth factor serum levels in portal and systemic serum. Several growth
factors are produced by the liver, whereas others are known to be extracted by the liver. Also,
some growth factors are produced by organs and tissues which have their venous drainage
only via the portal vein. These facts initiated the comparative study of growth factor levels in
portal and systemic serum. It appeared that, except for insulin, the serum levels of the studied
growth factors were comparable in both serum types. Insulin levels were higher in portal than
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in systemic serum. Furthermore, the senrm growth factor response was compared in patients
after partial hepatectomy in whom blood loss was low (< 1200 mL) with that in patients in
whom blood loss was high (>2500 mL). This comparison revealed that the amount of blood
loss did not influence serum growth factor response. Additionally. a comparison in growth
factor levels was made in patients after right lobectomy versus those after left lobectomy.
EGF response was higher in patients after right lobectomy than after left lobectomy. Possit,ly
this difference can be explained by a difference in EGF receptor status between the right and
left lobe of the l iver. IGF-I serum levels were lower in right lobectomy than in lefï lobectomy
patients, and the most l ikely explanation is that after right lobectomy a larger amount of IGF-i
synthetic capacity has been removed than after left lobectomy.
Another treatment modality for (irresectable) colorectal liver metastases is destruction of
metastases by cryosurgery. Because cryosurgery is not associated with removal of liver tissue,
a regeneration response is not occurring. Because of this it is expected that changes in serum
growth factor levels associated with regeneration, do not occur after cryosurgery. On the other
hand, in comparison to patients treated by partial liver resection, the extent of injury in cryo
surgically treated patients is expected to be higher, because necrotic tumor is left in situ and
initiates an ongoing inflammatory response. In order to compare the extent of injury and the
growth factor response in these two patient groups, acute phase proteins, HGF, and IL-6
serum response is described in chapter 9. This study revealed that in cryosurgically treated
patients the HGF and IL-6 response is comparable to that in patients after partial hepatectomy.
The acute phase response was higher in patients who underwent cryosurgery than in patients
after liver resection.
Conclusions
-l- Increased tumor growth after partial l iver resection is well established in
experimental animals. It is not restricted solely to the in vivo situation, but also in vitro
experiments revealed that tumor cell growth can be stimulated by factors in serum obtained
from partially hepatectomized rats.
-2- The influence of serum on in vitro tumor cell proliferation, is in the experimental
animal model dependent on the time lapse after partial l iver resection" Differences in
tumor cell proliferation were found only in cultures with serum obtained at day 3 and day l4
after operation, but not in cultures with day I serum.
-3- EGFr expression on cultured CC531 tumor cells is not influenceci by the type of
serum added to the culture medium, and is therefore not an explanation for the
differences in tumor cell proliferation in the studied animal model. In fact, no EGFr
expression was found on the used CC531 cells.
-4- PCNA expression and flow cytometric analysis of the number of S-phase nuclei
appear to be reliable methods for quantifying l iver cell proliferation in l ivers containing
metastases. These two techniques, can replace standard techniques tbr quantifying cell
proliferation, which are potentially dangerous to use in human research.
-5- In human colorectal l iver metastases, EGFr expression, absence of p53 expression
and higher TGFc expression than in the primary tumor are associated with an
unfavorable prognosis. Both primary tumor characteristics and survival after partial liver




-6- Recombinant human IL-6 induces a dose dependent HGF serum response. In cancer
patients, participating in a phase l-ll trial, solely administered IL-6 resulted in an increase of
HGF serum levels. This finding confirms that the relation between IL-6 and HGF, which was
proven in animal models, also exists in the human situation.
-7 - Only the acute phase and IGF-I serum response are different in partially
hepatectomized patients than in patients after laparotomy. The search for growth factors,
responsible for liver regeneration and the enhancement of tumor growth in humans, was not
(yet) successful. Of the growth factors studied in this thesis only IGF-I serum levels were
lower in hepatectomized patients as compared to laparotomized patients. Also, the acute phase
protein serunr levels in hepatectomized patients were lower than in laparotomized or
cryosurgically treated patients.
-8- HGF behaves l ike an acute phase protein. The very close resemblance of HGF senrm
levels and acute phase proteins after laparotomy and cryosurgery suggests that HGF is more
behaving like an acute phase protein than as a liver regeneration factor.
-9- The comparison of growth factor levels in portal versus systemic serum only revealed
a difference in insulin levels. As a possible explanation for dilferences in growth rate of
tumors in the liver and elsewhere, growth factor levels were analyzedin portal and systemic
senrm. No differences for EGF, HGF, iL-6 and IGF-I in both sera were found. Only insulin
levels were higher in portal than in systemic serum.
-10- EGF and IGF-I response is different after right lobectomy as compared with left
lobectomy. The finding that right lobectomy is associated with a higher EGF and a lower
IGF-I response, requires additional studies, but can possibly be explained by differences in
the right and left liver lobe regarding (EGF) receptor status and (IGF-I) synthetic capacity.
Samenvatting, discussie en conclusies
De incidentie van het colorectale carcinoom staat bij mannen (na long en prostaat carcinoom)
op de derde, en bij vrouwen (na het mammacarcinoom) op de tweede plaats. Chirurgische
verwijdering is de standaard therapie en leidt tot een 5-jaars overleving van ongeveer 50%.
Levermetastasen komen bij 40 tot 70oÁ van de patiënten met een colorectaal carcinoom voor.
Blj 10-15% van de patiënten is de lever aanvankelijk het enige aangedane orgaan en zou
partiële leverresectie tot genezing kunnen leiden. Slechts 25oÁ van de aldus behandelde
patienten bereikt een definitieve genezing.
De lever bezit het unieke vermogen zich te herstellen wanneer er sprake is geweest van
weefselverlies of beschadiging. Dit herstel treedt op door de uitgroei van resterend normaal
leverweefsel. Dit proces wordt regeneratie genoemd. Verschillende groeifactoren en
cytokines, die zowel door de lever zelf als door andere organen en weefsels worden
geproduceerd, reguleren dit proces. Ook tumorcellen, hoewel deze zich in het algemeen meer
autonoom gedragen dan niet-getransformeerde cellen, zijn afhankelijk van groeifactoren. De
gemeenschappelijke rol die groeifactoren spelen bij levenegeneratie n tumorgroei, leidde tot
de volgende hypothese: veranderingen in serumgroeifactor concentraties, optredend tijdens
leverregeneratie na pafiiële leverresectie, kunnen van invloed zijn op de groei van niet
detecteerbare micrometastasen. Deze hypothese wordt in dit proefschrift op twee manieren
getoetst. In een dierexperimenteel model en door besfudering van senrm groeifactor
concentraties en groeifactor(receptor) expressie bij patiënten met colorectale levermetastasen.
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